Compare FATE & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | MYPS |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | 568 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 64.2M |
| IPO Year | 2013 | N/A |
| Metric | FATE | MYPS |
|---|---|---|
| Price | $1.34 | $0.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $4.10 | $2.00 |
| AVG Volume (30 Days) | ★ 1.5M | 316.1K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,646,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $0.43 |
| 52 Week High | $1.94 | $1.68 |
| Indicator | FATE | MYPS |
|---|---|---|
| Relative Strength Index (RSI) | 49.31 | 44.45 |
| Support Level | $0.96 | $0.43 |
| Resistance Level | $1.35 | $0.53 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 20.43 | 63.31 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.